Online Only Articles

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;Department of Epidemiology, University of Washington, Seattle, WA, USA
SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands
Division of Hematology, VU University Medical Center, Amsterdam, The Netherlands
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA
Department of Medical Oncology, University Hospital, Bern, Switzerland
Department of Hematology, Cliniques Universitaires Saint-Luc UCL, Brussels, Belgium
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA
Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA
Vol. 100 No. 10 (2015): October, 2015 https://doi.org/10.3324/haematol.2015.130013